Epstein Barr intsholongwane VCA IgM ELISA Kit

Inkcazelo emfutshane:

Isetyenziselwa ukufumanisa umgangatho we-IgM-class antibodies kwi-Epstein-barr virus capsid antigen kwi-serum yabantu okanye iplasma.Yenzelwe ukuba isetyenziswe kwiilabhoratri zeklinikhi zokuxilongwa kunye nokulawulwa kwezigulane ezinxulumene nosulelo lwe-Epstein-barr virus.

Usulelo lwe-EBV luxhaphakile, ngaphezu kwe-90% yabemi behlabathi bosulelwe yintsholongwane, kwaye i-EBV ibonakaliswe njengosulelo olufihlakeleyo, kunye nosulelo oluphambili lwenzeka kwiintsana kunye nabafikisayo, ikakhulu njenge-asymptomatic, kunye nolutsha olubonisa i-mononucleosis esosulelayo.Emva kosulelo lokuqala, i-EBV ihlala ibambekile kwii-lymphocyte ze-B ezikhulileyo.Ngaphantsi kweemeko ezithile, i-virus efihliweyo inokuthi isebenze, ivuselela ukwanda kweeseli kunye nokuhlukana, kwaye kwezinye iimeko, ekugqibeleni iguqule izifo ezinobungozi ezifana ne-lymphoma, kunye ne-prognosis embi, ngoko ke ukufumanisa kwangaphambili kwe-EBV akufanele kuhoywe.

I-EBV ngomnye woonobangela bezifo ezininzi (umz. i-nasopharyngeal carcinoma) kwaye ikakhulu yosulela iiseli ze-epithelial kunye ne-B lymphocytes kwi-oropharynx yabantu.Uvavanyo lwe-EBV lunovavanyo lwe-antibody kunye ne-antigen.Iimvavanyo ze-antibody ze-EBV ziquka izilwa-buhlungu ezinxulumene ne-viral capsid antigen (VCA), i-antigen yokuqala (EA), i-viral nuclear antigen (EBNA), kunye ne-antigen ye-membrane (i-MA), kwaye ziqhele ukusetyenziswa ekliniki ukubona i-EB-VCA-IgM kunye ne-EB-VCA. -IgG.Uvavanyo lwe-EB-VCA-IgM lufumanisa i-antibodies kwisigaba esinzima sesigulane, kwaye umphumo omuhle wale nto usekuqaleni, isiseko esicacileyo kunye nobuthathaka bokuxilongwa kwekliniki.